1. Home
  2. IKT vs SHIP Comparison

IKT vs SHIP Comparison

Compare IKT & SHIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IKT
  • SHIP
  • Stock Information
  • Founded
  • IKT 2008
  • SHIP 2008
  • Country
  • IKT United States
  • SHIP Greece
  • Employees
  • IKT N/A
  • SHIP N/A
  • Industry
  • IKT Biotechnology: Pharmaceutical Preparations
  • SHIP Marine Transportation
  • Sector
  • IKT Health Care
  • SHIP Consumer Discretionary
  • Exchange
  • IKT Nasdaq
  • SHIP Nasdaq
  • Market Cap
  • IKT 140.5M
  • SHIP 127.2M
  • IPO Year
  • IKT 2020
  • SHIP 2007
  • Fundamental
  • Price
  • IKT $1.94
  • SHIP $6.78
  • Analyst Decision
  • IKT Buy
  • SHIP Strong Buy
  • Analyst Count
  • IKT 2
  • SHIP 1
  • Target Price
  • IKT $8.00
  • SHIP $11.00
  • AVG Volume (30 Days)
  • IKT 529.3K
  • SHIP 97.6K
  • Earning Date
  • IKT 08-13-2025
  • SHIP 08-05-2025
  • Dividend Yield
  • IKT N/A
  • SHIP 11.29%
  • EPS Growth
  • IKT N/A
  • SHIP 48.17
  • EPS
  • IKT N/A
  • SHIP 1.26
  • Revenue
  • IKT N/A
  • SHIP $153,372,000.00
  • Revenue This Year
  • IKT N/A
  • SHIP N/A
  • Revenue Next Year
  • IKT N/A
  • SHIP $21.78
  • P/E Ratio
  • IKT N/A
  • SHIP $5.44
  • Revenue Growth
  • IKT N/A
  • SHIP 17.53
  • 52 Week Low
  • IKT $1.12
  • SHIP $4.78
  • 52 Week High
  • IKT $4.20
  • SHIP $12.65
  • Technical
  • Relative Strength Index (RSI)
  • IKT 52.68
  • SHIP 53.50
  • Support Level
  • IKT $1.81
  • SHIP $6.32
  • Resistance Level
  • IKT $2.09
  • SHIP $6.60
  • Average True Range (ATR)
  • IKT 0.14
  • SHIP 0.22
  • MACD
  • IKT 0.02
  • SHIP -0.03
  • Stochastic Oscillator
  • IKT 71.70
  • SHIP 57.93

About IKT Inhibikase Therapeutics Inc.

Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease (PD), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.

About SHIP Seanergy Maritime Holdings Corp.

Seanergy Maritime Holdings Corp is an international shipping company that provides marine dry bulk transportation services through the ownership and operation of dry bulk vessels. It generates a majority of its revenue from the vessels. The company's fleet of vessels includes Fellowship, Championship, Partnership, Knightship, Lordship, Gloriuship, Leadership, Geniuship, Premiership, and Squireship, among others.

Share on Social Networks: